CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Lexicon - LXRX CFD

    2.51
    7.72%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.05
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Lexicon Pharmaceuticals Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    Key Stats
    Prev. Close* 2.72
    Open* 2.67
    1-Year Change* 50%
    Day's Range* 2.44 - 2.67
    52 wk Range 1.31-3.79
    Average Volume (10 days) 5.05M
    Average Volume (3 months) 29.81M
    Market Cap 520.35M
    P/E Ratio -100.00K
    Shares Outstanding 244.85M
    Revenue 126.00K
    EPS -0.63
    Dividend (Yield %) N/A
    Beta 1.27
    Next Earnings Date Jul 31, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 2, 2023 2.72 -0.03 -1.09% 2.75 2.77 2.64
    Jun 1, 2023 2.68 0.00 0.00% 2.68 2.70 2.54
    May 31, 2023 3.27 0.39 13.54% 2.88 3.39 2.87
    May 30, 2023 2.86 -0.52 -15.38% 3.38 3.43 2.65
    May 26, 2023 3.14 0.12 3.97% 3.02 3.20 2.90
    May 25, 2023 2.86 -0.17 -5.61% 3.03 3.03 2.83
    May 24, 2023 2.98 -0.04 -1.32% 3.02 3.02 2.94
    May 23, 2023 3.02 -0.16 -5.03% 3.18 3.27 3.02
    May 22, 2023 3.17 0.10 3.26% 3.07 3.27 3.03
    May 19, 2023 2.97 0.04 1.37% 2.93 3.00 2.86
    May 18, 2023 2.86 -0.04 -1.38% 2.90 2.91 2.76
    May 17, 2023 2.89 -0.04 -1.37% 2.93 2.94 2.84
    May 16, 2023 2.90 -0.03 -1.02% 2.93 2.95 2.81
    May 15, 2023 2.94 0.06 2.08% 2.88 3.01 2.84
    May 12, 2023 2.83 -0.29 -9.29% 3.12 3.16 2.81
    May 11, 2023 3.10 0.06 1.97% 3.04 3.17 2.98
    May 10, 2023 3.03 -0.13 -4.11% 3.16 3.16 2.91
    May 9, 2023 3.00 -0.24 -7.41% 3.24 3.24 2.96
    May 8, 2023 3.23 -0.27 -7.71% 3.50 3.53 3.20
    May 5, 2023 3.45 0.36 11.65% 3.09 3.75 3.05

    Lexicon Events

    Time (UTC) Country Event
    Monday, July 31, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q2 2023 Lexicon Pharmaceuticals Inc Earnings Release
    Q2 2023 Lexicon Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    Tuesday, November 7, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q3 2023 Lexicon Pharmaceuticals Inc Earnings Release
    Q3 2023 Lexicon Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0.139 0.298 23.995 322.073 63.209
    Revenue 0.139 0.298 23.995 322.073 63.209
    Cost of Revenue, Total 0 0 1.929 3.231 2.491
    Gross Profit 0.139 0.298 22.066 318.842 60.718
    Total Operating Expense 100.899 87.388 70.792 180.628 166.488
    Selling/General/Admin. Expenses, Total 48.083 32.342 47.23 56.835 63.754
    Research & Development 52.816 55.046 153.621 91.924 100.243
    Other Operating Expenses, Total 0 0
    Operating Income -100.76 -87.09 -46.797 141.445 -103.279
    Interest Income (Expense), Net Non-Operating -2.78 -0.802 -14.544 -20.676 -20.777
    Other, Net 1.596 0.134 2.767 3.35 3.508
    Net Income Before Taxes -101.944 -87.758 -58.574 124.119 -120.548
    Net Income After Taxes -101.944 -87.758 -58.574 130.133 -120.548
    Net Income Before Extra. Items -101.944 -87.758 -58.574 130.133 -120.548
    Net Income -101.944 -87.758 -58.574 130.133 -120.548
    Income Available to Common Excl. Extra. Items -101.944 -87.758 -58.574 130.133 -120.548
    Income Available to Common Incl. Extra. Items -101.944 -87.758 -58.574 130.133 -120.548
    Diluted Net Income -101.944 -87.758 -58.574 130.133 -120.548
    Diluted Weighted Average Shares 165.733 145.652 110.841 116.747 105.83
    Diluted EPS Excluding Extraordinary Items -0.61511 -0.60252 -0.52845 1.11466 -1.13907
    Diluted Normalized EPS -0.61511 -0.60252 -1.71924 1.2741 -1.13907
    Total Extraordinary Items 0
    Unusual Expense (Income) 0 0 -131.988 28.638
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 0.024 0.028 0.039 0.035 0.037
    Revenue 0.024 0.028 0.039 0.035 0.037
    Cost of Revenue, Total
    Gross Profit
    Total Operating Expense 31.166 30.306 23.134 24.042 23.417
    Selling/General/Admin. Expenses, Total 19.14 16.329 12.577 10.686 8.491
    Research & Development 12.026 13.977 10.557 13.356 14.926
    Operating Income -31.142 -30.278 -23.095 -24.007 -23.38
    Interest Income (Expense), Net Non-Operating -1.821 -1.103 -0.864 -0.703 -0.11
    Other, Net 1.029 0.887 0.572 0.123 0.014
    Net Income Before Taxes -31.934 -30.494 -23.387 -24.587 -23.476
    Net Income After Taxes -31.934 -30.494 -23.387 -24.587 -23.476
    Net Income Before Extra. Items -31.934 -30.494 -23.387 -24.587 -23.476
    Net Income -31.934 -30.494 -23.387 -24.587 -23.476
    Income Available to Common Excl. Extra. Items -31.934 -30.494 -23.387 -24.587 -23.476
    Income Available to Common Incl. Extra. Items -31.934 -30.494 -23.387 -24.587 -23.476
    Diluted Net Income -31.934 -30.494 -23.387 -24.587 -23.476
    Diluted Weighted Average Shares 189.014 188.98 174.904 149.616 149.15
    Diluted EPS Excluding Extraordinary Items -0.16895 -0.16136 -0.13371 -0.16433 -0.1574
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.16895 -0.16136 -0.13371 -0.16433 -0.1574
    Unusual Expense (Income) 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 140.866 88.921 157.719 337.754 173.324
    Cash and Short Term Investments 138.357 86.743 152.275 271.659 160.052
    Cash & Equivalents 46.345 64.065 126.263 36.112 80.386
    Short Term Investments 92.012 22.678 26.012 235.547 79.666
    Total Receivables, Net 0.028 0.014 0.395 56.532 5.924
    Accounts Receivable - Trade, Net 0.028 0.014 0.395 56.532 5.924
    Prepaid Expenses 2.481 2.164 5.049 5.32 2.668
    Total Assets 194.299 136.909 203.788 417.715 284.136
    Property/Plant/Equipment, Total - Net 4.371 3.476 1.495 15.747 15.865
    Property/Plant/Equipment, Total - Gross 8.355 8.329 7.31 77.488 75.871
    Accumulated Depreciation, Total -3.984 -4.853 -5.815 -61.741 -60.006
    Goodwill, Net 44.543 44.543 44.543 44.543 44.543
    Intangibles, Net 0 19.716 50.119
    Other Long Term Assets, Total 4.519 -0.031 0.031 -0.045 0.285
    Total Current Liabilities 23.172 22.124 46.806 65.341 36.751
    Accounts Payable 10.395 9.152 5.469 12.178 17.759
    Accrued Expenses 12.373 10.469 29.691 42.151 14.482
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 11.646 11.012 1.115
    Other Current Liabilities, Total 0.404 2.503 0 3.395
    Total Liabilities 77.175 23.314 47.417 300.614 310.541
    Total Long Term Debt 48.579 0 0 234.171 243.887
    Long Term Debt 48.579 0 234.171 243.887
    Deferred Income Tax 0 6.014
    Other Liabilities, Total 5.424 1.19 0.611 1.102 23.889
    Total Equity 117.124 113.595 156.371 117.101 -26.405
    Common Stock 0.189 0.15 0.142 0.106 0.106
    Additional Paid-In Capital 1709.14 1608.75 1561.1 1462.17 1447.95
    Retained Earnings (Accumulated Deficit) -1589.72 -1487.78 -1400.02 -1341.44 -1471.58
    Treasury Stock - Common -2.061 -7.518 -4.843 -3.817 -2.876
    Other Equity, Total -0.428 -0.01 -0.006 0.084 -0.012
    Total Liabilities & Shareholders’ Equity 194.299 136.909 203.788 417.715 284.136
    Total Common Shares Outstanding 188.726 148.917 141.496 106.272 105.926
    Total Inventory 0 4.243 4.68
    Redeemable Preferred Stock 0 0 0 0 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 109.546 140.866 139.063 64.898 88.431
    Cash and Short Term Investments 105.937 138.357 136.203 61.968 86.502
    Cash & Equivalents 26.001 46.345 18.834 21.45 59.52
    Short Term Investments 79.936 92.012 117.369 40.518 26.982
    Total Receivables, Net 0.261 0.028 0.039 0.034 0.037
    Accounts Receivable - Trade, Net 0.261 0.028 0.039 0.034 0.037
    Prepaid Expenses 3.348 2.481 2.821 2.896 1.892
    Total Assets 162.716 194.299 191.685 112.325 136.178
    Property/Plant/Equipment, Total - Net 8.627 4.371 8.032 2.835 3.242
    Property/Plant/Equipment, Total - Gross 6.303 8.355 6.109 6.105 6.104
    Accumulated Depreciation, Total -4.096 -3.984 -5.177 -5.07 -4.962
    Goodwill, Net 44.543 44.543 44.543 44.543 44.543
    Other Long Term Assets, Total 4.519 0.047 0.049 -0.038
    Total Current Liabilities 20.371 23.172 18.445 16.862 18.905
    Accounts Payable 10.311 10.395 9.427 7.347 9.321
    Accrued Expenses 9.576 12.373 8.299 9.038 8.864
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Total Liabilities 74.67 77.175 47.667 41.495 43.48
    Total Long Term Debt 48.845 48.579 23.784 23.631 23.477
    Other Liabilities, Total 5.454 5.424 5.438 1.002 1.098
    Total Equity 88.046 117.124 144.018 70.83 92.698
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.19 0.189 0.189 0.15 0.15
    Additional Paid-In Capital 1712.56 1709.14 1705.61 1608.73 1605.9
    Retained Earnings (Accumulated Deficit) -1621.65 -1589.72 -1559.23 -1535.84 -1511.25
    Treasury Stock - Common -2.885 -2.061 -2.061 -2.061 -2.061
    Other Equity, Total -0.163 -0.428 -0.491 -0.15 -0.037
    Total Liabilities & Shareholders’ Equity 162.716 194.299 191.685 112.325 136.178
    Total Common Shares Outstanding 189.562 188.726 188.726 149.626 149.594
    Other Current Liabilities, Total 0.484 0.404 0.719 0.477 0.72
    Long Term Debt 48.845 48.579 23.784 23.631 23.477
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -101.944 -87.758 -58.574 130.133 -120.548
    Cash From Operating Activities -88.851 -87.017 -142.969 113.807 -148.607
    Cash From Operating Activities 0.427 0.292 2.934 3.654 3.683
    Deferred Taxes 0 0 -6.014 0
    Non-Cash Items 12.264 10.68 -118.408 44.321 13.032
    Cash Interest Paid 2.289 0.799 17.353 19.211 16.465
    Changes in Working Capital 0.402 -10.231 31.079 -58.287 -44.774
    Cash From Investing Activities -71.078 2.11 380.756 -155.855 169.576
    Capital Expenditures -1.326 -1.221 -0.087 -0.07 -0.095
    Other Investing Cash Flow Items, Total -69.752 3.331 380.843 -155.785 169.671
    Cash From Financing Activities 142.209 22.709 -147.636 -2.226 -2.244
    Issuance (Retirement) of Stock, Net 93.341 34.409 68.944 -0.941 -0.24
    Issuance (Retirement) of Debt, Net 48.868 -11.7 -216.58 -1.285 -2.004
    Net Change in Cash -17.72 -62.198 90.151 -44.274 18.725
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -31.934 -101.944 -71.45 -48.063 -23.476
    Cash From Operating Activities -31.613 -88.851 -67.282 -47.843 -23.421
    Cash From Operating Activities 0.112 0.427 0.324 0.216 0.109
    Non-Cash Items 3.68 12.264 8.648 5.783 2.797
    Cash Interest Paid 1.556 2.289 1.281 0.634 0.085
    Changes in Working Capital -3.471 0.402 -4.804 -5.779 -2.851
    Cash From Investing Activities 12.093 -71.078 -95.252 -18.056 -4.408
    Capital Expenditures -0.248 -1.326 -0.08 -0.076 -0.076
    Other Investing Cash Flow Items, Total 12.341 -69.752 -95.172 -17.98 -4.332
    Cash From Financing Activities -0.824 142.209 117.303 23.284 23.284
    Issuance (Retirement) of Stock, Net -0.824 93.341 93.404 -0.864 -0.864
    Issuance (Retirement) of Debt, Net 0 48.868 23.899 24.148 24.148
    Net Change in Cash -20.344 -17.72 -45.231 -42.615 -4.545
    Deferred Taxes
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Artal International S.C.A. Investment Advisor 45.506 86262020 0 2023-03-31 LOW
    BVF Partners L.P. Hedge Fund 8.5192 16149179 0 2023-03-31 LOW
    Ulys, L.L.C. Investment Advisor 2.7979 5303814 0 2022-08-01
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.792 5292626 43032 2023-03-31 LOW
    Fidelity Management & Research Company LLC Investment Advisor 2.7644 5240247 -11438 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 2.6709 5062976 -201281 2023-03-31 LOW
    Invus Public Equities Advisors, LLC Investment Advisor 1.8549 3516214 0 2023-03-31 LOW
    JP Morgan Asset Management Investment Advisor 1.6081 3048374 56229 2023-03-31 LOW
    D. E. Shaw & Co., L.P. Hedge Fund 1.5515 2940997 -136976 2023-03-31 LOW
    New Enterprise Associates (NEA) Venture Capital 1.2567 2382286 0 2023-03-31 LOW
    Pinnacle Associates Ltd. Investment Advisor/Hedge Fund 1.0235 1940224 7447 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9102 1725409 117468 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.8251 1564098 47623 2023-03-31 LOW
    Coats Lonnel Individual Investor 0.3927 744359 158356 2023-02-28 LOW
    Fisher Investments Investment Advisor/Hedge Fund 0.38 720243 0 2023-03-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.3794 719182 306384 2023-03-31 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.3633 688611 -7329 2023-03-31 LOW
    Parkman Healthcare Partners LLC Hedge Fund 0.3563 675328 254126 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.3561 675018 -19915 2023-03-31 LOW
    Asset Management One Co., Ltd. Investment Advisor/Hedge Fund 0.3194 605528 605528 2022-08-31 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Bio Therapeutic Drugs

    8800 Technology Forest Place
    8800 Technology Forest Place
    77381

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Oil - Crude

    71.97 Price
    -0.040% 1D Chg, %
    Biaya inap posisi Long -0.0149%
    Biaya inap posisi short -0.0070%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    XRP/USD

    0.51 Price
    -7.390% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00384

    BTC/USD

    25,777.35 Price
    -5.490% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    US100

    14,540.70 Price
    -0.120% 1D Chg, %
    Biaya inap posisi Long -0.0255%
    Biaya inap posisi short 0.0032%
    Waktu biaya inap 21:00 (UTC)
    Spread 1.8

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda